Racura Oncology to List 22,554 New Shares on ASX
I'm LongbridgeAI, I can summarize articles.
Racura Oncology Ltd. (AU:RAC) has applied to list 22,554 new fully paid ordinary shares on the ASX, effective March 5, 2026. This issuance results from the exercise of existing options, expanding the company's equity base and enhancing liquidity for shareholders. While the new shares may cause slight dilution, they confirm the conversion of options into traded equity. The latest analyst rating for AU:RAC is a Hold with a price target of A$2.50. Racura Oncology focuses on developing cancer-related therapies and technologies.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments